These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3017797)

  • 1. Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors.
    Lager I; Attvall S; Eriksson BM; von Schenk H; Smith U
    Diabetologia; 1986 Jul; 29(7):409-16. PubMed ID: 3017797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline.
    Attvall S; Fowelin J; von Schenck H; Smith U; Lager I
    J Clin Endocrinol Metab; 1992 May; 74(5):1110-5. PubMed ID: 1569157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the insulin-antagonistic effect of growth hormone in man.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
    Diabetologia; 1991 Jul; 34(7):500-6. PubMed ID: 1916055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between some beta-adrenergic mediated responses and plasma concentrations of adrenaline and cyclic AMP in man.
    Philipsen EK; Myhre J; Larsen S; Damkjaer Nielsen M; Holst JJ; Hilsted J
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):115-20. PubMed ID: 1968306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.
    William-Olsson T; Fellenius E; Björntorp P; Smith U
    Acta Med Scand; 1979; 205(3):201-6. PubMed ID: 218427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the insulin-antagonistic effect of growth hormone in insulin-dependent diabetes mellitus.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
    Diabet Med; 1995 Nov; 12(11):990-6. PubMed ID: 8582132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.
    Attvall S; Eriksson BM; Fowelin J; von Schenck H; Lager I; Smith U
    J Clin Invest; 1987 Aug; 80(2):437-42. PubMed ID: 2886515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.
    Attvall S; Fowelin J; von Schenck H; Lager I; Smith U
    Diabetologia; 1987 Sep; 30(9):691-7. PubMed ID: 2828139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine-induced insulin resistance in man.
    Deibert DC; DeFronzo RA
    J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
    Flaten O; Sand T; Myren J
    Scand J Gastroenterol; 1982 Mar; 17(2):283-8. PubMed ID: 6127792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D; MacDonald IA; Heller SR; Tattersall RB
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog.
    Chu CA; Sindelar DK; Igawa K; Sherck S; Neal DW; Emshwiller M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E463-73. PubMed ID: 10913048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients.
    Groop L; Tötterman KJ; Harno K; Gordin A
    Acta Med Scand; 1983; 213(1):9-14. PubMed ID: 6338683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.